Rybelsus® is an innovative prescription medication developed by Novo Nordisk, designed to help adults with type 2 diabetes manage their blood sugar levels and support weight loss . Unlike many other GLP-1 receptor agonists that require injection, Rybelsus is the first in its class to be available in an oral tablet form, offering a convenient option for patients.
How Rybelsus Works ?
Rybelsus contains the active ingredient semaglutide, which mimics the action of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). This hormone plays a crucial role in regulating blood sugar levels by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying. By replicating these effects, Rybelsus helps improve glycemic control in individuals with type 2 diabetes.
Benefits of Rybelsus
Oral Convenience: As the first and only oral GLP-1 receptor agonist, Rybelsus eliminates the need for injections, making diabetes management easier and more accessible for patients.
Effective Blood Sugar Control: Clinical studies have shown that Rybelsus significantly lowers HbA1c levels, providing effective blood sugar control.
Weight Management: In addition to controlling blood sugar, Rybelsus may help support weight loss, a beneficial side effect for many individuals with type 2 diabetes.
Who Should Use Rybelsus
Rybelsus® is indicated for adults with type 2 diabetes to improve blood sugar control as part of a comprehensive treatment plan that includes diet and exercise. It is particularly suitable for those who prefer an oral medication over injectable options.
Eligibility Criteria
Type 2 Diabetes: Rybelsus® is specifically designed for individuals with type 2 diabetes. It helps improve glycemic control and can be a part of your diabetes management plan.
Non-Injectable Option: If you are looking for a convenient, non-injectable alternative to manage your type 2 diabetes, Rybelsus® may be the right choice.
Important Considerations
Not for Type 1 Diabetes or DKA: Rybelsus® is not recommended for patients with type 1 diabetes or diabetic ketoacidosis (DKA).
Pregnancy and Breastfeeding: Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as Rybelsus® may not be suitable.
Other Health Conditions: If you have any other significant health conditions, discuss with your healthcare provider to determine if Rybelsus® is appropriate for you.
At SLIM for LIFE, we are available to help answer any questions you might have about Rybelsus® or other aspects of diabetes management. Feel free to contact us for more information or assistance
Possible Side Effects ?
As with any medication, Rybelsus may cause side effects. Common side effects include nausea, vomiting, diarrhea, decreased appetite, and stomach pain. Most side effects are mild and tend to decrease over time. It is important to discuss any concerns or severe side effects with a healthcare provider.
What is the difference between Saxenda® vs. Rybelsus®
Purpose and Indication:
Saxenda®:
- Indication: Saxenda® is primarily used for weight management in adults with obesity or overweight conditions.
- Eligibility: It is prescribed for individuals with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as high blood pressure or type 2 diabetes.
Rybelsus®:
- Indication: Rybelsus® is used to improve blood sugar control in adults with type 2 diabetes.
- Eligibility: It is part of a comprehensive diabetes treatment plan, including diet and exercise.
Active Ingredient:
Saxenda®:
- Active Ingredient: Liraglutide, which is a GLP-1 receptor agonist that mimics the effects of the GLP-1 hormone.
Rybelsus®:
- Active Ingredient: Semaglutide, another GLP-1 receptor agonist that aids in blood sugar regulation.
Administration:
Saxenda®:
- Form: Injectable.
- Administration: Saxenda® is administered once daily via injection.
Rybelsus®:
- Form: Oral tablet.
- Administration: Rybelsus® is taken orally once daily, at least 30 minutes before the first meal, beverage, or other oral medications of the day.
Primary Benefits:
Saxenda®:
- Aids in weight loss and weight management.
- Supports lifestyle changes such as a reduced-calorie diet and increased physical activity.
Rybelsus®:
- Helps lower blood sugar levels in type 2 diabetes.
- Offers the convenience of an oral medication for those who prefer not to use injections.
Suitability and Considerations:
Saxenda®:
- Not suitable for individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
- Should not be used during pregnancy or breastfeeding.
Rybelsus®:
- Not suitable for patients with type 1 diabetes or diabetic ketoacidosis.
- Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
Both medications are part of the GLP-1 receptor agonist class but are designed for different primary purposes—weight management versus blood sugar control in diabetes. Always consult with a healthcare provider to determine which medication is suitable for your specific health needs.
English 
Svenska